Clinical Trials
All Clinical Trials - Page 11 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06374875Phase 4Recruiting
Fibrosis Lessens After Metabolic Surgery
Tirzepatide
- NCT06254014Phase 3Active Not Recruiting
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
Exenatide
- NCT06581120N/AEnrolling By Invitation
GLP_1 RA Ultrasound Study
Tirzepatide
- NCT06986993Phase 4Recruiting
Impact of Semaglutide on Tobacco Use and Related Health Behaviors
Semaglutide
- NCT06082063Phase 3Recruiting
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Semaglutide
- NCT06487832N/ARecruiting
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
Semaglutide
- NCT06686134N/ARecruiting
Comprehensive Clinical Evaluation Study of GLP-1RA
Semaglutide
- NCT06598839N/ARecruiting
Immuno-effect of Tα1 for Stage I NSCLC
Thymosin-Alpha-1
- NCT06545994N/ARecruiting
A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS
Kisspeptin
- NCT06515418Phase 2Terminated
Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
Tirzepatide
- NCT06482411N/ACompleted
Risk Factors Affect Weight Loss Outcomes After Treatment.
Liraglutide
- NCT06478550N/ACompleted
A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This Treatment
Semaglutide
- NCT06720246N/ARecruiting
Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity
Liraglutide
- NCT06388187Phase 3Completed
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
Semaglutide
- NCT06500429Phase 2Completed
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
Semaglutide
- NCT06440980Phase 1Completed
A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
Orforglipron
- NCT06461910Phase 2Recruiting
Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
Thymosin-Alpha-1
- NCT06466486Phase 1Terminated
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation
Gonadorelin
- NCT06461377Phase 4Recruiting
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
Semaglutide
- NCT06338553EARLY_Phase 1Recruiting
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
Semaglutide
- NCT06283667N/AActive Not Recruiting
Special Use - Results Surveillance on Long-term Use With Wegovy®
Semaglutide
- NCT05897398N/ACompleted
SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®
Semaglutide
- NCT06050577Phase 2Active Not Recruiting
The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial
Semaglutide
- NCT06363487N/ACompleted
Semaglutide and Cognition in Healthy Volunteers
Semaglutide
- NCT06439277Phase 3Recruiting
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Tirzepatide
- NCT06378866Phase 2Recruiting
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Gonadorelin
- NCT06451120Phase 2Recruiting
Platelet Rich Plasma Injections In Young And Old Human Subjects
Ghrp-6
- NCT06481696N/AUnknown
Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility
Gonadorelin
- NCT06435702N/ANot Yet Recruiting
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study
Gonadorelin
- NCT02586831Phase 1/Phase 2Withdrawn
Diabetes Islet Preservation Immune Treatment
Exenatide
- NCT06263595N/ACompleted
Semaglutide and Preoperative Residual Gastric Volumes
Semaglutide
- NCT06373731Phase 3Active Not Recruiting
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
Elamipretide
- NCT06490328Phase 3Recruiting
Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer
Gonadorelin
- NCT06500130N/ACompleted
Effects of Liraglutide on Body Surface Gastric Mapping
Liraglutide
- NCT06439056Phase 1Completed
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Liraglutide
- NCT06395753Phase 2Active Not Recruiting
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Gonadorelin
- NCT06445075Phase 2Completed
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Tirzepatide
- NCT06400615Phase 2Completed
Study That Tests AD109 in Patients Taking GLP-1 Drugs
Tirzepatide
- NCT06409130Phase 2Completed
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
Semaglutide
- NCT06925334Phase 4Enrolling By Invitation
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
Liraglutide
- NCT06312670Phase 2Completed
Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer
Gonadorelin
- NCT06318442N/ARecruiting
The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
Semaglutide
- NCT06352411Phase 1Completed
A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems
Survodutide
- NCT06403761Phase 1Completed
Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
Semaglutide
- NCT06449703Phase 1Unknown
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects
Liraglutide
- NCT06370728Phase 1Completed
A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
Orforglipron
- NCT06438146Phase 4Unknown
LIROH - Liraglutide for Obesity in HIV
Liraglutide
- NCT06383390Phase 3Active Not Recruiting
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Retatrutide
- NCT06423599Phase 2/Phase 3Recruiting
Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
Semaglutide
- NCT06408532Phase 4Unknown
The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
Liraglutide